BRD2 and Dravet syndrome: In a follow-up study, the authors administered follicle-stimulating hormone (FSH) to a group of normo-ovulatory DS vs. control individuals and found a significant impairment in the ovarian sensitivity to FSH, as measured by estradiol production [183], and potentially contributing to gonadal disfunction in T21 women [184].